Impact BioMedical Inc. (IBO)
AMEX: IBO
· Real-Time Price · USD
0.58
0.01 (2.29%)
At close: Aug 15, 2025, 3:59 PM
0.56
-2.75%
After-hours: Aug 15, 2025, 07:32 PM EDT
Impact BioMedical Cash Flow Statement
Financials in CAD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -23.77M | -24.77M | 1.1M | -3.14M | -2.26M | -1.75M | -1.28M | -2.12M | -8.67M | -9.36M | -9.61M | -10.5M | -3.97M | -2.88M | -1.92M | -259.25K | -290.65K |
Depreciation & Amortization | 839.41K | 1.12M | 1.12M | 839.38K | 560.75K | 353.07K | 142.49K | 208.44K | 287.24K | 286.49K | 286.01K | 266.4K | 187.31K | 115.82K | 46.95K | 306.00 | 305.00 |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | 25.7K | 23.11K | 120.68K | 242.63K | 257.01K | 212.5K | 903.54K | 781.59K | 741.51K | 808.02K | 19.4K | 19.4K |
Other Working Capital | -114.84K | -300K | -301K | -19.06K | 7.06K | 192.06K | 55.52 | 113.93 | n/a | n/a | n/a | n/a | 6.69K | 81.21K | 64.6K | 57.34K | 72.97K |
Other Non-Cash Items | 20.11M | 20.34M | -5.67M | 217.32 | 230.35K | 17.67K | 44.99K | 44.77K | 2.68M | 2.66M | 2.63M | 2.79M | 160.37K | 160.39K | 160.48K | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 210K | 210K | 2.92M | 2.92M | 2.71M | 2.71M | 25.00 | 25.00 | 25.00 | n/a | n/a |
Change in Working Capital | -613.84K | -608K | 352K | 491.07K | 554.06K | 747.17K | 207.28K | 434.83K | -267.52K | -169.63K | -275.86K | -507.7K | 208.5K | -18.27K | 63.72K | 57.51K | 64.81K |
Operating Cash Flow | -3.44M | -3.92M | -3.1M | -1.81M | -916.88K | -607.03K | -654.63K | -1.1M | -2.82M | -3.41M | -4.04M | -4.33M | -2.63M | -1.88M | -841.69K | -182.04K | -206.13K |
Capital Expenditures | n/a | n/a | n/a | n/a | -15.9 | -42.76K | -253.54K | -396.78K | -408.54K | -449.71K | -238.92K | -95.68K | -83.91K | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 618.01K | 618.01K | 618.01K | -2.05M | -2.67M | -2.67M | -2.67M | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 2K | 2K | 3K | 2K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | 42.93K | 42.93K | 42.93K | 67.93K | 25K | 25K |
Investing Cash Flow | 2K | 2K | 3K | 2K | 985.43 | -41.75K | -253.54K | -396.78K | 209.48K | 168.31K | 390.95K | -2.09M | -2.7M | -2.61M | -2.6M | 25K | 25K |
Debt Repayment | 1.71M | 2.19M | 1.83M | 1.61M | 715K | 232K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.6K | -1.6K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.73M | 3.73M | 3.73M | 1.18K | 2.17K | 382.17K | 564.42K | 1.15M | 1.12M | 721.74K | 528.5K | 1.28M | 4.17M | 6.22M | 6.26M | 4.96M | 2.1M |
Financial Cash Flow | 5.43M | 5.92M | 5.56M | 1.61M | 717.17K | 610.1K | 557.81K | 1.13M | 1.01M | 357.28K | 166.57K | 7.01M | 10M | 12.4M | 12.44M | 5.07M | 2.28M |
Net Cash Flow | 2M | 2M | 2.47M | -198.73K | -198.73K | -38.68K | -350.36K | -373K | -1.6M | -2.88M | -3.49M | 583.85K | 4.67M | 7.91M | 9M | 4.91M | 2.1M |
Free Cash Flow | -3.44M | -3.92M | -3.1M | -1.81M | -916.9K | -649.78K | -908.17K | -1.5M | -3.22M | -3.86M | -4.28M | -4.43M | -2.71M | -1.88M | -841.69K | -182.04K | -206.13K |